Provider review
Mochi Health tirzepatide review
What Mochi Health charges, what is included, who prescribes, which pharmacy fills it, where it operates — and how much of that we confirmed ourselves rather than took from the website.
Read on Mochi Health’s own pages on November 20, 2026: medication priced to your dose from $90 a month at the starting dose, plus a required membership of $79 a month or $49 a month on a 12-month plan. It scores 68/100 under our written v4.1 scoring guide, #9 of 22 programs scored.
What is distinctive about this programme
Read the total, not the medication line
Mochi's advertised medication prices — $99 semaglutide and $199 tirzepatide — are among the lowest anywhere. The required $79 monthly membership makes the actual totals $178 and $278, which places the programme mid-table rather than at the top.
This is the clearest example in our dataset of why we publish totals. A comparison ranking on the medication column alone would place Mochi first for semaglutide; on the total it sits eighth.
What the membership buys
Unlimited physician and dietitian access is a substantive inclusion rather than a platform fee. At $948 a year it is not cheap, but a patient who will actually use clinical and dietetic support is buying something real, and several cheaper all-inclusive competitors provide less contact.
The $39 first-month membership rate is an introductory price that rises to $79. We exclude introductory rates from every ranking on this site, because they apply to one month of an indefinite treatment.
Flat across doses
Price is reported as the same at all doses, which removes escalation risk. Commitment tiers are reported to reduce the membership component.
Show this figure as a table
| Item | Value | Evidence |
|---|---|---|
| Semaglutide injectable | $178 | Provider-reported |
| Tirzepatide injectable | $278 | Provider-reported |
Where it holds up
- Same price at all doses, removing escalation risk
- Membership includes unlimited physician and dietitian access, not just platform access
- Commitment tiers reduce the membership component
- Medication pricing is genuinely low before the membership
Where it does not
- Membership is required, and it roughly doubles the semaglutide medication price
- The $39 first-month membership is introductory and rises to $79
- Total cost places the programme mid-table despite a market-leading medication price
- Figures are third-party reported and not yet captured by us
| Field | Position |
|---|---|
| Membership | Separate and required |
| Dose structure | Escalates with dose or not established |
| Lowest captured figure | $178/mo, month-to-month |
| Evidence status | Third-party reported, pending our own capture |
| Pharmacy named to us | No — provider-reported only |
| Category | Points |
|---|---|
| Pricing transparency | 20 |
| Total annual cost | 20 |
| Clinical oversight | 15 |
| Pharmacy transparency | 15 |
| Support | 10 |
| Regulatory disclosure | 10 |
| Accessibility | 10 |
Pricing, all-in
Plan total and monthly equivalent are calculated by us from the provider's published figures, using the same formula applied to every provider on this site. A price is only a price once the required fees are inside it.
| Provider | Program | Formulation | Dose coverage | Medication | Required fees | All-in monthly | Price type | Evidence | Captured |
|---|---|---|---|---|---|---|---|---|---|
| Mochi Health | month_to_month | compounded injectable | not recorded | $278 | not verified | $278 | Recurring | Provider-reported | 2026-07-06 |
| Mochi Health | month_to_month | compounded injectable | not recorded | $178 | not verified | $178 | Recurring | Provider-reported | 2026-07-06 |
How this sits against the market
The July 2026 all-provider chart that stood here has been retired. Current first-party prices for 28 compounded tirzepatide programs (read October 15, 2026; NexLife November 20, 2026) are on the price index.
Show this figure as a table
| Component | Amount |
|---|---|
| Medication | not captured |
| Membership | not captured |
| Shipping | not captured |
| Dose surcharge | not captured |
| Consultation | not captured |
| Labs | not captured |
| All-in total | not captured |
| Cost component | Inside the advertised figure? | Charged anyway? |
|---|---|---|
| Medication | yes | yes |
| Membership or program fee | no | not verified |
| Shipping | no | not verified |
| Higher-dose surcharge | no | not verified |
| Initial consultation | no | not verified |
| Required laboratory work | no | not verified |
| Cancellation or restocking terms | no | not verified |
This chart stays empty until two or more dated captures exist. Historical values are never estimated or backfilled from a provider's current page.
Show this figure as a table
| Item | This provider | Category median |
|---|---|---|
| All-in monthly | not captured | not captured |
| Membership fee | not captured | not captured |
| Rubric score | not captured | not captured |
What is included, and what is not
Where it holds up
- nothing verified yet
Where it does not
- nothing verified yet
Where it operates
State availability is verified against the provider's own checkout or a support confirmation, state by state, with a capture date. A provider serving forty states is not nationwide, and we do not describe it that way.
Show this figure as a table
| Status | Records | Share |
|---|---|---|
| Researched and verified | 0 | 0% |
| Not yet researched | 51 | 100% |
Pharmacy and fulfilment
What changed
Show this figure as a table
| No events recorded. |
- no entriesNothing has changed yet because nothing has been published yet. Entries appear here when a verified figure, score or conclusion changes, never for a typo fix.
How this compares to the category
Once enough providers are scored, this section reports where Mochi Health sits against the median for each rubric category, not against a hand-picked competitor.
| Question | Worth | Their answer | Status |
|---|---|---|---|
| Pharmacy traceability and quality disclosures | 15 pts | not verified | Not answered Verification pending |
| Clinical oversight and care continuity | 20 pts | not verified | Not answered Verification pending |
| State access and operational reliability | 10 pts | not verified | Not answered Verification pending |
| Cancellation, billing and support transparency | 10 pts | not verified | Not answered Verification pending |
Questions readers actually ask
Is Mochi Health the cheapest option?
Read on its own page on November 20, 2026: medication priced to your dose from $90 a month at the starting dose, plus a required membership of $79 a month or $49 a month on a 12-month plan.
Is compounded tirzepatide the same as Zepbound?
Mochi Health scores 68/100 under the written v4.1 scoring guide, #9 of 22 programs scored from pages read November 20–21, 2026. Its weakest category is pharmacy transparency (2 of 15).
Related on this site
- All provider reviewsProviders
- NexLife Tirzepatide ReviewProviders
- Ro Body Tirzepatide ReviewProviders
- Hims & Hers Tirzepatide ReviewProviders
- Provider ranking methodologyCore & Trust
- GLP-1 total cost calculatorTools
- Download the pricing recordsData
- Eden Tirzepatide ReviewProviders
- The Hidden Cost of GLP-1 Membership FeesJournal
- NexLife vs Mochi HealthComparisons
Related coverage
GLP-1 Tirzepatide Review. “Mochi Health Tirzepatide Review.” S.J Partners LLC, 2026-07-26. https://glptirzepatidereview.com/providers/mochi-health/
When quoting a figure, include the capture date shown beside it rather than the date you read this page. A price without its capture date is not a usable citation.